ModivCare (MODV)
(Delayed Data from NSDQ)
$26.04 USD
+0.71 (2.80%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $26.02 -0.02 (-0.08%) 7:58 PM ET
5-Strong Sell of 5 5
B Value F Growth F Momentum D VGM
ModivCare (MODV) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$35.80 | $50.00 | $25.00 | 41.33% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for ModivCare comes to $35.80. The forecasts range from a low of $25.00 to a high of $50.00. The average price target represents an increase of 41.33% from the last closing price of $25.33.
Analyst Price Targets (5 )
Broker Rating
ModivCare currently has an average brokerage recommendation (ABR) of 1.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 2.20 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, three are Strong Buy, representing 60% of all recommendations. A month ago, Strong Buy represented 40%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/MODV.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.80 | 1.80 | 2.20 | 2.20 | 2.20 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/9/2024 | Barrington Research | Michael J Petusky | Hold | Strong Buy |
6/3/2024 | Stephens | Scott Fidel | Strong Buy | Strong Buy |
5/6/2024 | Lake Street Capital Markets | Brooks G O'Neil | Hold | Strong Buy |
2/23/2024 | Not Identified | Not Identified | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.80 |
ABR (Last week) | 1.80 |
# of Recs in ABR | 5 |
Average Target Price | $35.80 |
LT Growth Rate | 7.20% |
Industry | Medical Services |
Industry Rank by ABR | 165 of 253 |
Current Quarter EPS Est: | 0.91 |